Objective UNISEC brings together a European consortium of 3 University partners, 5 National Health Institutes and 3 SMEs, all with leading expertise in influenza vaccine research and development, to work on promising recently developed concepts for a universal influenza vaccine. The consortium is exceptionally strong, interdisciplinary and intersectional in nature, and encompasses a unique combination of scientific and technological expertise from lead identification to clinical trial execution.UNISEC will bring a number of vaccine concepts together into a single study in order to identify, develop and clinically test the 3 most promising leads for a universal influenza vaccine, which must (1) demonstrate adequate (universal) protection, and (2) be technically suitable for development to a marketable product.Preclinical and clinical methodologies will be developed allowing a comparative evaluation of the vaccine concepts. Head-to-head comparisons in animal models will also be performed, with the most promising concepts to then be ready for clinical assessment. Independent comparative clinical studies will be executed and carried out by 5 established Clinical Trial Site partners.The expected impact of the UNISEC work programme will be the resolution of current problems of non-uniformity in the development and evaluation of universal influenza vaccines in Europe by a unified approach using an expert and sustainable vaccine expertise network. The UNISEC results will directly contribute to a timely, longer-term, broader, more effective and cost-effective universal influenza vaccine for the prevention of annual and pandemic influenza.The success of UNISEC will be based on the leading experience of its consortium partners; the proven track record of its clinical trial site partners; and a coherent and well-defined management structure and dissemination program, underpinned by the fact that several UNISEC partners were previously part of the successful EU FLUSECURE project. Fields of science medical and health scienceshealth sciencesinfectious diseasesRNA virusesinfluenzamedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines Programme(s) FP7-HEALTH - Specific Programme "Cooperation": Health Topic(s) HEALTH.2013.2.3.0-1 - Innovation in vaccines Call for proposal FP7-HEALTH-2013-INNOVATION-1 See other projects for this call Funding Scheme CP-FP - Small or medium-scale focused research project Coordinator RIJKSUNIVERSITEIT GRONINGEN EU contribution € 1 345 917,76 Address Broerstraat 5 9712CP Groningen Netherlands See on map Region Noord-Nederland Groningen Overig Groningen Activity type Higher or Secondary Education Establishments Administrative Contact Dick Veldhuis (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Participants (12) Sort alphabetically Sort by EU Contribution Expand all Collapse all ACADEMISCH ZIEKENHUIS GRONINGEN Netherlands EU contribution € 601 066,80 Address HANZEPLEIN 1 9713 GZ Groningen See on map Region Noord-Nederland Groningen Overig Groningen Activity type Higher or Secondary Education Establishments Administrative Contact Johanna M Van Apeldoorn (Mrs.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data PEPTCELL LTD United Kingdom EU contribution € 721 127,91 Address Fetter Lane 100 EC4A 1BN LONDON See on map Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Administrative Contact Gregory Stoloff (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data BIONDVAX PHARMACEUTICALS LTD Israel EU contribution € 564 557,75 Address EINSTEIN STREET 14 74036 NES ZIONA See on map Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Administrative Contact Tanya Gottlieb (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data RETROSCREEN VIROLOGY LTD United Kingdom EU contribution € 25 317,60 Address NEW ROAD QUEEN MARY BIOENTERPRISE INNOVATION CENTRE 42 E1 2AX LONDON See on map Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Administrative Contact John Oxford (Prof.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Department of Health United Kingdom EU contribution € 485 631,75 Address Quarry House, Quarry Hill LS2 7UE Leeds See on map Region Yorkshire and the Humber West Yorkshire Leeds Activity type Research Organisations Administrative Contact Amanda King (Ms.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data STATENS SERUM INSTITUT Denmark EU contribution € 547 233,60 Address ARTILLERIVEJ 5 2300 Kobenhavn S See on map Region Danmark Hovedstaden Byen København Activity type Research Organisations Administrative Contact Dennis Christensen (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data ORSZAGOS EPIDEMIOLOGIAI KOZPONT Hungary EU contribution € 358 610,80 Address ALBERT FLORIAN UTCA 2-6 1097 Budapest See on map Region Közép-Magyarország Budapest Budapest Activity type Higher or Secondary Education Establishments Administrative Contact Ildiko Visontai (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data FOLKEHELSEINSTITUTTET Norway EU contribution € 356 791,20 Address LOVISENBERGGATA 8 0456 Oslo See on map Region Norge Oslo og Viken Oslo Activity type Research Organisations Administrative Contact Kjerstin Klevdal Nielsen (Mrs.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data ROBERT KOCH-INSTITUT Germany EU contribution € 538 225,67 Address Nordufer 20 13353 Berlin See on map Region Berlin Berlin Berlin Activity type Research Organisations Administrative Contact Birgit Arnold (Mrs.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data GOETEBORGS UNIVERSITET Sweden EU contribution € 427 699,66 Address VASAPARKEN 405 30 Goeteborg See on map Region Södra Sverige Västsverige Västra Götalands län Activity type Higher or Secondary Education Establishments Administrative Contact Ellen Rydberg (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data NOVAVAX AB Participation ended Sweden EU contribution No data Address KUNGSGATAN 109 753 18 Uppsala See on map Region Östra Sverige Östra Mellansverige Uppsala län Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Administrative Contact Erik Bergman (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Medicines and Healthcare products Regulatory Agency Participation ended United Kingdom EU contribution No data Address Buckingham Palace Road SW1W 9SZ London See on map Administrative Contact Amanda King (Ms.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data
